Garrett Murrin, a representative of Radiant Life Technologies, presents a new perspective on neuropathy. Many individuals suffering from nerve damage are often told that nothing more can be done once standard medical interventions have been exhausted. This webinar challenges that notion by examining the limitations of the current 'control' and 'replace' medical paradigms and introducing a 'support' paradigm through coMra therapy.
In the conventional medical model, the primary focus is on symptom management—often through pain medication—and identifying the underlying cause of the nerve damage. While surgical interventions like nerve grafting exist, they are highly specific and limited in application. The implicit message in these approaches is often a 'wait and see' strategy, relying on the body's spontaneous self-repair. If that repair does not occur, the patient is frequently told that no further progress is possible.
Garrett Murrin argues that we do not have to rely solely on spontaneous recovery. By using coMra therapy, it is possible to directly enhance the nerve's own ability to self-repair. This does not mean abandoning conventional medicine; rather, coMra therapy is designed to work in conjunction with existing treatments. By providing the necessary support to damaged but living nerve cells, this approach aims to improve outcomes for those suffering from both acute and chronic nerve damage, regardless of the initial cause.